ECCO 15 -- ESMO 34 multidisciplinary cancer congress
ECCO 15 ESMO
34 will take place at the ICC Berlin Internationales Congress Centrum, Messedamm 22, D-14055 Berlin, Germany ( www.icc-berlin.de ) from Sunday 20 September to Thursday 24 September 2009.
ECCO 15 ESMO
34 will build on the success of the previous ECCO (European Cancer Conference) ...
2nd ESMO symposium on soft tissue carcinomas and GIST
Experts in treating a rare group of cancers that affect tissues such as muscle, fat, nerves and the gastrointestinal wall are meeting in Milan, Italy on 13-14 May to discuss the latest information on how these diseases develop and potential new avenues for therapy.
The 2nd Symposium on Sarcoma ...
Handbook of cancer prevention launched by ESMO
A new publication designed to help individuals, doctors and governments reduce the global burden of cancer has been announced today by Europes leading society for medical oncologists.
Handbook of Cancer Prevention, from the European Society for Medical Oncology, contains state-of-the-a...
Transatlantic alliance supports breast cancer research
...n translational research will discuss cutting-edge treatments that are now moving from laboratories into the clinical setting. Komen will also support esmo
research fellowships in preeminent cancer centers in Western Europe to offer doctors from Eastern European countries the opportunity to learn the newe...
New data on link between cancer and nutrition discussed at European symposium
The latest research findings on these topics will be discussed at the esmo
Symposium on Cancer and Nutrition (20-21 March 2009), organized by the Euro...the advice given to people is based on proper scientific evidence."
Symposium will discuss the latest evidence on the link between diet and can...
GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
...ures 2008. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf . Accessed January 28, 2009.
(2) Eichhorst B. Chronic lymphocytic leukemia: esmo
Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008. 19:60-62. doi:10.1093/annonc/mdn090.
(3) Leukemia and Lymphoma Soci...
Get the latest on premier science in medical oncology
...reate lively discussions on hot topics.
The 7th esmo
Patient Seminar where patients will have the chanc...t state-of-the-art oncology.
The fifth batch of esmo
Designated Centers of Integrated Oncology and Pall...llence for patient care in Europe.
A session on esmo
Clinical Recommendations will update current...
10th World Congress on Gastrointestinal Cancer -- Barcelona, Spain
... As it celebrates its 10th year, the esmo
International Symposium: 10th World Congress on Gastrointestinal Cancer has...g the medical community and look forward to continuing the journey."
International Symposium: 10th World Congress on Gastrointestinal Cancer, de...
Symposium focuses on curable cancer that affects young men
...e adopted course," Prof. Schmoll continued.
Symposium on Testicular Cancer will present cuttin...eeting, the Symposium Faculty will convene for the esmo
International Consensus meeting on Testicular Tumo...al important topics in the field and to update the esmo
Clinical Recommendations (CR) on Testicular semino...
European Society for Medical Oncology and European CanCer Organization join forces
...n-numbered years between the ECCO-ESMO congresses, esmo
will continue to hold its own esmo
Congress. In 2008, the 33rd esmo
Congress will take place as planned, 12-16 Septemb...
ESMO in Medical Technology
Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy
Interim data from Phase 1b Study indicate that adecatumumab in combination
with docetaxel is safe and well tolerated and suggest a better outcome for breast cancer patients with high EpCAM expression
BETHESDA, Md., Sept. 15 /PRNewswire-FirstCall/ -- Micromet, Inc.
(Nasdaq: MITI ), a...
Cougar Biotechnology Announces Presentation of Positive CB7630
Clinical Data at ESMO Conference
LOS ANGELES--(BUSINESS WIRE)--July 8, 2007 - Cougar Biotechnology,
Inc. (OTCBB:CGRB) today announced that positive Phase I and Phase
II data on the Company's prostate cancer drug candidate CB7630
(abiraterone acetate) were presented at the European Society for
Medical Oncology (ESMO) Conference, wh...
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
...; Session ID: Clinical Research 10).
The abstract of this poster has been published today (09-AB-5492-AACR).
"Data to be presented at the AACR and esmo
conferences, combined with rash being reported independent of the KRAS status of patients, are in sharp contrast to the dated speculation that toxicit...
Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology
...ct #768O) V. Chiarion Sileni - Oral presentation from 3:30 p.m. to
5:30 p.m. local time on Monday, September 15, 2008.
More information about the esmo
Congress may be found at http://www.esmo.org . About Medarex
Medarex is a biopharmaceutical company focused on the discovery,
development and pote...
European Society for Medical Oncology (ESMO) Presents Data from the
Clinical Trial of MediGene's Cancer-Killing Virus in Press
...e I/II trial
of oncolytic HSV * Poster selected by esmo
for presentation in
MARTINSRIED...take place on Friday, July 6, at 12:30 MEST at
conference in Lugano, Switzerland (ECLU). Dr. Axel...nalysis of this
study. The poster presented at the esmo
conference shows efficacy
data in a case study for...
MediGene Announces Cancer-Fighting Virus Shows Promise in Early
...a preliminary study,
researchers said today at the esmo
Conference Lugano (ECLU),
The virus...ltidisciplinary cancer treatment around
the world. esmo
unites medical oncologists, oncology specialists,
... state-of-the-art education and training programs, esmo
instrumental role in providing the oncolo...
ESMO in Biological News
European Multidisciplinary Conference on Thoracic Oncology
...resenters of the studies, both in presence and remotely. Please contact the esmo
Communication Dept. at email@example.com to already find out about the preli...newsroom/events/ and send the Complimentary Media Registration form to the esmo
For hotel reservation, pleas...
New treatment approach promising for lymphoma patients in the developing world
...patients with aggressive non-Hodgkin's lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say.
At the esmo
Conference Lugano (ECLU) organized by the European Society for Medical Oncology, a group headed by Prof. Hamdy Azim from Cairo University reports that...
Treatment delays result in poor outcomes for men with breast cancer
...lthough most breast cancer patients are women, men make up roughly 1% of cases, Dr. Marina Garassino from the Orion Collaborative Group reports at the esmo
Conference Lugano (ECLU), organized by the European Society for Medical Oncology.
Her group conducted a retrospective analysis of 146 men with inv...
Counting tumor cells in blood predicts treatment benefit in prostate cancer
...am of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show.
At the esmo
Conference Lugano (ECLU) organized by the European Society for Medical Oncology, researchers showed that changes in the number of circulating tumor ce...
First European Lung Cancer Conference
...for Medical Oncology (ESMO), the European Lung Cancer Conference will be held biennially, alternating with the World Conference on Lung Cancer and the esmo
chest tumors conference. The event will gather top multidisciplinary experts to provide the audience (European and worldwide) with state-of-the-art ed...
ESMO International Symposium on Immunology
...cs in the field of tumor immunology and immunotherapy will be discussed by international experts to the benefit of young cancer specialists during the esmo
International Symposium (EIS) on Immunology.
Immunology has come to stay in oncology: this EIS symposium will offer a comprehensive overview of the in...
ESMO in Biological Technology